Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
<strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/8/6/941 |
id |
doaj-08c55ab4f5714d9fa8f01af6a473456e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stefano Leo Vladimir Lazarevic Myriam Girard Nadia Gaïa Jacques Schrenzel Victoire de Lastours Bruno Fantin Marc Bonten Yehuda Carmeli Emilie Rondinaud Stephan Harbarth Benedikt D. Huttner |
spellingShingle |
Stefano Leo Vladimir Lazarevic Myriam Girard Nadia Gaïa Jacques Schrenzel Victoire de Lastours Bruno Fantin Marc Bonten Yehuda Carmeli Emilie Rondinaud Stephan Harbarth Benedikt D. Huttner Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial Microorganisms Fecal microbiota transplantation extended-spectrum beta-lactamase-producing Enterobacteriaceae carbapenemase-producing Enterobacteriaceae microbiome whole metagenome shotgun sequencing |
author_facet |
Stefano Leo Vladimir Lazarevic Myriam Girard Nadia Gaïa Jacques Schrenzel Victoire de Lastours Bruno Fantin Marc Bonten Yehuda Carmeli Emilie Rondinaud Stephan Harbarth Benedikt D. Huttner |
author_sort |
Stefano Leo |
title |
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial |
title_short |
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial |
title_full |
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial |
title_fullStr |
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial |
title_full_unstemmed |
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial |
title_sort |
metagenomic characterization of gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation: results from a multicenter randomized trial |
publisher |
MDPI AG |
series |
Microorganisms |
issn |
2076-2607 |
publishDate |
2020-06-01 |
description |
<strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Here, we characterized the temporal dynamics of fecal microbiota changes in a sub-cohort of the R-GNOSIS WP3 participants before and after antibiotics/FMT using whole metagenome shotgun sequencing. <strong>Methods:</strong> We sequenced fecal DNA obtained from 16 ESBL-E/CPE carriers having received oral colistin/neomycin followed by FMT and their corresponding seven donors. Ten treatment-naïve controls from the same trial were included. Fecal samples were collected at baseline (V0), after antibiotics but before FMT (V2) and three times after FMT (V3, V4 and V5). <strong>Results:</strong> Antibiotic treatment transiently decreased species richness and diversity and increased the abundance of antibiotic resistance determinants (ARDs). <em>Bifidobacterium</em> species, together with butyrate- and propionate-producing species from Lachnospiraceae and Ruminococcaceae families were significantly enriched in post-FMT microbiota of treated carriers. After FMT, the proportion of Enterobacteriaceae was lower compared to baseline but without statistical significance. <strong>Conclusions:</strong> Combined antibiotic and FMT treatment resulted in enrichment of species that are likely to limit the gut colonization by ESBL-E/CPE. |
topic |
Fecal microbiota transplantation extended-spectrum beta-lactamase-producing Enterobacteriaceae carbapenemase-producing Enterobacteriaceae microbiome whole metagenome shotgun sequencing |
url |
https://www.mdpi.com/2076-2607/8/6/941 |
work_keys_str_mv |
AT stefanoleo metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT vladimirlazarevic metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT myriamgirard metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT nadiagaia metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT jacquesschrenzel metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT victoiredelastours metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT brunofantin metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT marcbonten metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT yehudacarmeli metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT emilierondinaud metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT stephanharbarth metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial AT benediktdhuttner metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial |
_version_ |
1724478057030352896 |
spelling |
doaj-08c55ab4f5714d9fa8f01af6a473456e2020-11-25T03:53:25ZengMDPI AGMicroorganisms2076-26072020-06-01894194110.3390/microorganisms8060941Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized TrialStefano Leo0Vladimir Lazarevic1Myriam Girard2Nadia Gaïa3Jacques Schrenzel4Victoire de Lastours5Bruno Fantin6Marc Bonten7Yehuda Carmeli8Emilie Rondinaud9Stephan Harbarth10Benedikt D. Huttner11Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandDivision of Internal Medicine, Beaujon Hospital, APHP, Boulevard du Général Leclerc 100, 92110 Clichy, FranceDivision of Internal Medicine, Beaujon Hospital, APHP, Boulevard du Général Leclerc 100, 92110 Clichy, FranceDepartment of Medical Microbiology, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, The NetherlandsNational Institute for Antibiotic Resistance and Infection Control, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Weizmann Street 6, 6423906 Tel Aviv, IsraelDepartment of Medical Microbiology, APHP, Bichat-Claude-Bernard Hospital, Rue Henri Huchard 46, 75018 Paris, FranceDivision of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, SwitzerlandDivision of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland<strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Here, we characterized the temporal dynamics of fecal microbiota changes in a sub-cohort of the R-GNOSIS WP3 participants before and after antibiotics/FMT using whole metagenome shotgun sequencing. <strong>Methods:</strong> We sequenced fecal DNA obtained from 16 ESBL-E/CPE carriers having received oral colistin/neomycin followed by FMT and their corresponding seven donors. Ten treatment-naïve controls from the same trial were included. Fecal samples were collected at baseline (V0), after antibiotics but before FMT (V2) and three times after FMT (V3, V4 and V5). <strong>Results:</strong> Antibiotic treatment transiently decreased species richness and diversity and increased the abundance of antibiotic resistance determinants (ARDs). <em>Bifidobacterium</em> species, together with butyrate- and propionate-producing species from Lachnospiraceae and Ruminococcaceae families were significantly enriched in post-FMT microbiota of treated carriers. After FMT, the proportion of Enterobacteriaceae was lower compared to baseline but without statistical significance. <strong>Conclusions:</strong> Combined antibiotic and FMT treatment resulted in enrichment of species that are likely to limit the gut colonization by ESBL-E/CPE.https://www.mdpi.com/2076-2607/8/6/941Fecal microbiota transplantationextended-spectrum beta-lactamase-producing Enterobacteriaceaecarbapenemase-producing Enterobacteriaceaemicrobiomewhole metagenome shotgun sequencing |